Press Releases

NEW YORK, March 2, 2020 /PRNewswire/ -- The National Kidney Foundation (NKF) is joining forces with the U.S. Department of Health and Human Services (HHS), the American Society of Nephrology (ASN), and actor Wilmer Valderrama to reach the 1 in 3 American adults at risk for kidney disease. "

MOUNTAIN VIEW, Calif., March 2, 2020 /PRNewswire/ -- AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, today announced the appointment of Siva Somayajula, as its Chief Technology Officer.

PLYMOUTH MEETING, Pa., March 2, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that fourth quarter and full year 2019 financial results will be released after the market close on March 12, 2020. Following the release, the Company will host a live conference call and webcast at 4:30 p.m

ANNAPOLIS, Md., March 2, 2020 /PRNewswire/ -- Recognized every March, Bleeding Disorders Awareness Month increases understanding and fosters advocacy for the bleeding disorders community, including people living with hemophilia, von Willebrand Disease, and other rare bleeding disorders. The 

RYE BROOK, N.Y., March 2, 2020 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) announced today three new appo

SAN DIEGO, March 2, 2020 /PRNewswire/ -- Neurelis, Inc., announced today the commercial availability of VALTOCO® (diazepam nasal spray) for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in adult and ped

FORT WORTH, Texas, March 2, 2020 /PRNewswire/ -- Eyevance Pharmaceuticals, committed to developing and commercializing innovative and impactful ophthalmic products, is pleased to announce the United States launch of TOBRADEX® ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% following the Company's acqu

CAMPBELL, Calif., March 2, 2020 /PRNewswire/ -- VivaLNK, a leading provider of connected healthcare solutions, announces a multi-patient remote monitoring solution with Alibaba. The solution

NEW YORK, March 2, 2020 /PRNewswire/ -- The Conrad N. Hilton Foundation will invest USD $500,000 to support the sight-saving work Orbis International carries out on its Flying Eye Hospital, the world's only fully accredited ophthalmic teaching hospital on board an MD-10 aircraft.

SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implemented an enterprise-wide compliance risk assessment since